Use access key #2 to skip to page content.
$0.97 0.09 (10.45%)
10/15/2008 3:55 PM

GPC Biotech AG (ADR) (GPCB)

CAPS Rating:
*

The Company is publicly traded biopharmaceutical company focused on discovering, developing and commercializing new anticancer drugs.

View All Commentary (GPCB)

Recs

0

Avatar smith45416 (< 20) Submitted: 6/13/08 8:46 PM : Outperform Start Price: $4.21 GPCB Score: -43.84

How many times can you go wrong with a biopharmceutical company

Report this Post Replies: 0 | Reply

Featured Broker Partners

Sponsored Links